Helai Mohammad

Helai Mohammad is an accomplished scientist currently serving as Chief Scientific Officer at SK Life Science Labs since October 2024. Prior experience includes the role of Vice President and Head of Biology at Proteovant Therapeutics, where focus was on the development of disease-modifying therapies utilizing natural protein homeostasis. Previously, Helai held multiple positions at GSK from September 2011 to May 2021, culminating as Senior Director and GSK Senior Fellow. Research background includes a post-doctoral fellowship at The Johns Hopkins University School of Medicine, specializing in epigenetics and chromatin biology related to cancer, as well as foundational research during graduate studies at Case Western Reserve University into pituitary tumorigenesis. Helai's career commenced at Johns Hopkins University, initially serving as Research Program Coordinator/Supervisor. Educational credentials comprise a PhD in Pharmacology from Case Western Reserve University and a B.A. from The Johns Hopkins University.